You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD19 lymphoid malignancies

Showing 1 - 25 of 4,207
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • São Paulo, Brazil
    Hospital Israelita Albert Einstein
Jan 20, 2023

Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +15 more
  • Anti-CD19/CD20/CD22 CAR T-Cells
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 4, 2022

Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

Recruiting
  • Non Hodgkin Lymphoma
  • +2 more
  • Fully human anti CD19 CAR-T Cell Dose
  • +2 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Oct 4, 2022

B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Taipei (RPM

Terminated
  • B-cell Acute Lymphoblastic Leukemia
  • +7 more
  • RPM CD19-mbIL15-CAR-T cells
  • Taipei, Taiwan
    National Taiwan University Hospital
May 11, 2022

Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Beijing (CAR-NK-CD19 Cells)

Recruiting
  • Acute Lymphocytic Leukemia
  • +2 more
  • CAR-NK-CD19 Cells
  • Beijing, Beijing, China
    Beijing Boren Hospital
Jun 5, 2022

Non-Hodgkin's Lymphoma (Disorder), Acute Lymphoid Leukemia, Disease (Disorder) Trial in Louisville, Houston (1A46 Injection)

Recruiting
  • Non-Hodgkin's Lymphoma (Disorder)
  • Acute Lymphoid Leukemia, Disease (Disorder)
  • 1A46 Injection
  • Louisville, Kentucky
  • +1 more
Aug 1, 2022

Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Fairway, Houston (SC291)

Recruiting
  • Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Fairway, Kansas
  • +1 more
May 30, 2023

People Living With HIV Treated With CD19-directed CAR T Cell

Active, not recruiting
  • Leukemia
  • +9 more
    • Philadelphia, Pennsylvania
      Pennsylvania Hospital
    Mar 29, 2023

    B-cell Non Hodgkin Lymphoma, B-cell Chronic Lymphocytic Leukemia Trial in Milwaukee (Dose Level -1: 0.75x10^6 cells/kg

    Recruiting
    • B-cell Non Hodgkin Lymphoma
    • B-cell Chronic Lymphocytic Leukemia
    • Dose Level -1: 0.75x10^6 cells/kg CAR20.19.22 cells
    • +3 more
    • Milwaukee, Wisconsin
      Medical College of Wisconsin and Froedtert Hospital
    Jul 1, 2022

    Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

    Terminated
    Has Results
    • Lymphoma, B-Cell
    • +3 more
    • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

    Recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jul 14, 2022

    Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia in Remission
    • +10 more
    • CliniMACS
    • Houston, Texas
    • +1 more
    Dec 8, 2022

    Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin's Lymphoma Trial in Wuhan (Fludarabine + Cyclophosphamide

    Recruiting
    • Acute Lymphocytic Leukemia
    • +2 more
    • Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    Apr 5, 2021

    Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Lymphoma Trial in Dongguan (Drugs and Anti-CD19-CAR transduced T

    Completed
    • Acute Lymphocytic Leukemia
    • +2 more
    • Drugs and Anti-CD19-CAR transduced T cells
    • Dongguan, Guangdong, China
      Department of Hematology, Dongguan People's Hospital
    Mar 16, 2021

    B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic

    Terminated
    • B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
    • +16 more
    • Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 28, 2021

    CD19-positive Relapsed or Refractory B-cell Malignancies Trial in Hefei (UTAA09 cells for infusion, Fludarabine,

    Not yet recruiting
    • CD19-positive Relapsed or Refractory B-cell Malignancies
    • UTAA09 cells for infusion
    • +2 more
    • Hefei, Anhui, China
      The First Affiliated Hospital of USTC (AnHui Provincial Hospital
    Oct 13, 2023

    Acute Lymphoblastic Leukemia, Chronic Lymphoblastic Leukemia, B-cell Lymphoma Trial in Wuhan (Fludarabine + Cyclophosphamide +

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
    • Wuhan, Hubei, China
    • +1 more
    Mar 11, 2021

    Leukemia, Lymphoma Trial in Houston (HSCT, DLI)

    Completed
    • Leukemia
    • Lymphoma
    • HSCT
    • DLI
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 9, 2021

    B-Cell Leukemia, B-Cell Lymphoma, B-cell Tumors Trial in Kunming (Anti-CD19 Autologous CAR-T Cell Infusion)

    Recruiting
    • B-Cell Leukemia
    • +2 more
    • Anti-CD19 Autologous CAR-T Cell Infusion
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Jul 9, 2023

    Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • allogenic CD19-CAR-NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 11, 2023

    Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

    Not yet recruiting
    • Hematopoietic Stem Cell Transplantation
    • Hematologic Malignancy
    • CliniMACS®
    • (no location specified)
    Oct 17, 2023

    Adult Relapsed/Refractory B-cell Hematologic Malignancies Trial in Beijing (CD19-CAR-NK)

    Recruiting
    • Adult Relapsed/Refractory B-cell Hematologic Malignancies
    • CD19-CAR-NK
    • Beijing, Beijing, China
      The Fifth Medical Center of Chinese People's Liberation Army (PL
    Dec 1, 2022

    B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)

    Recruiting
    • B Cell Malignancies
    • Universal CD19-specific CAR gene-engineered T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 8, 2023